In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone

Health authorities carefully evaluate any change in the batch manufacturing process of a drug before and after regulatory approval. In the absence of an adequate in vitro–in vivo correlation (Level A IVIVC), an in vivo bioequivalence (BE) study is frequently required, increasing the cost and time of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosca, Elena M., Rocchetti, Maurizio, Pérez, Elena, Nieto, Conchi, Bettica, Paolo, Moscoso del Prado, Jaime, Magni, Paolo, De Nicolao, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918143/
https://www.ncbi.nlm.nih.gov/pubmed/33673306
http://dx.doi.org/10.3390/pharmaceutics13020255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918143/
https://www.ncbi.nlm.nih.gov/pubmed/33673306
http://dx.doi.org/10.3390/pharmaceutics13020255

Ejemplares similares